Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:
“Strategies to improve beyond KATHERINE
1. ASTEFANIA: TDM1+/-Atezolizumab
2. COMPASS HER2 RD: TDM1+/-Tucatinib
3. Destiny breast 05: TDM1 vs TdXD “
More posts featuring Akhil Santhosh
